Angelica Yinzi alleviates 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis by inhibiting activation of NLRP3 inflammasome and down-regulating the MAPKs/NF-kB signaling pathway

Angelica Yinzi alleviates 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis by inhibiting activation of NLRP3 inflammasome and down-regulating the MAPKs/NF-kB signaling pathway

Background: Atopic dermatitis (AD), characterized by eczema as a chronic pruritic inflammatory skin disease, has become a serious health problem with recurrent clinical episodes. However, current clinical treatments have limited relief and are accompanied by adverse effects. Therefore, there is a ne...

Full description

Bibliographic Details
Main Authors: Wei Liu, Wanci Song, Yang Luo, Hanxiong Dan, Li Li, Zhouyang Zhang, Daonian Zhou, Pengtao You
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Saudi Pharmaceutical Journal
Subjects:
Angelica Yinzi
Atopic dermatitis
MAPK
NLRP3
Inflammation
Online Access:http://www.sciencedirect.com/science/article/pii/S1319016422001955

Internet

http://www.sciencedirect.com/science/article/pii/S1319016422001955

Similar Items